Research theme for competitive and other funds (4):
2022 - 2025 神経芽腫の時期・細胞特異的な発生機構解明
2020 - 2022 Mechanism of neuroblastoma development caused by epigenetic abnormalities induced by MYCN and EZH2
2018 - 2020 Mechanism of neuroblastoma development by MYCN-PRC2 mediated epigenomic aberrations
2014 - 2017 MYCN-Tgマウスにおける神経芽腫発生の運命決定機構の解明
Papers (15):
Hiroki Kitai, Noritoshi Kato, Koichi Ogami, Shintaro Komatsu, Yu Watanabe, Seiko Yoshino, Eri Koshi, Shoma Tsubota, Yoshio Funahashi, Takahiro Maeda, et al. Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis. BMC biology. 2022. 20. 1. 248-248
Akihiro Ryuge, Tomoki Kosugi, Kayaho Maeda, Ryoichi Banno, Yang Gou, Kei Zaitsu, Takanori Ito, Yuka Sato, Akiyoshi Hirayama, Shoma Tsubota, et al. Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis. JCI Insight. 2021. 6. 20
Yosuke Komata, Shoma Tsubota, Kazuma Sakamoto, Shinya Ikematsu, Kenji Kadomatsu. Screening of novel Midkine binding protein by BioID2-based proximity labeling. Nagoya journal of medical science. 2021. 83. 3. 495-508
Yue Huang, Shoma Tsubota, Nobuhiro Nishio, Yoshiyuki Takahashi, Kenji Kadomatsu. Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells. Cancer science. 2021. 112. 2. 715-724